Omnicell is trading $40.00 (+7.24%) after rising sharply following the August 14, 2026 regular-session close, with no clear company-specific catalyst identified.

  • No new company-specific announcement, earnings release, filing, or analyst action clearly explained the move.
  • Recent coverage revisits July 30 earnings, including higher profitability guidance but wider product-bookings uncertainty.
  • Broader indices were mixed, so market direction does not clearly explain the gain.